TY - JOUR
T1 - Multiple downstream proarrhythmic targets for calmodulin kinase II
T2 - Moving beyond an ion channel-centric focus
AU - Anderson, Mark E.
N1 - Funding Information:
Ms. Sydney Harned and Ms. Arlinda LaRose provided excellent secretarial assistance and Mr. Shawn Roach for graphic design. We acknowledge support from the National Institutes of Health and the National Heart Lung and Blood Institute (HL070250, HL62494 and HL046681).
PY - 2007/3/1
Y1 - 2007/3/1
N2 - The multifunctional Ca2+ calmodulin-dependent protein kinase II (CaMKII) has emerged as a pro-arrhythmic signaling molecule. CaMKII can participate in arrhythmia signaling by effects on ion channel proteins, intracellular Ca2+ uptake and release, regulation of cell death, and by activation of hypertrophic signaling pathways. The pleuripotent nature of CaMKII is reminiscent of another serine-threonine kinase, protein kinase A (PKA), which shares many of the same protein targets and is the downstream kinase most associated with β-adrenergic receptor stimulation. The ability of CaMKII to localize and coordinate activity of multiple protein targets linked to Ca2+ signaling set CaMKII apart from other "traditional" arrhythmia drug targets, such as ion channel proteins. This review will discuss some of the biology of CaMKII and focus on work that has been done on molecular, cellular, and whole animal models that together build a case for CaMKII as a pro-arrhythmic signal and as a potential therapeutic target for arrhythmias and structural heart disease.
AB - The multifunctional Ca2+ calmodulin-dependent protein kinase II (CaMKII) has emerged as a pro-arrhythmic signaling molecule. CaMKII can participate in arrhythmia signaling by effects on ion channel proteins, intracellular Ca2+ uptake and release, regulation of cell death, and by activation of hypertrophic signaling pathways. The pleuripotent nature of CaMKII is reminiscent of another serine-threonine kinase, protein kinase A (PKA), which shares many of the same protein targets and is the downstream kinase most associated with β-adrenergic receptor stimulation. The ability of CaMKII to localize and coordinate activity of multiple protein targets linked to Ca2+ signaling set CaMKII apart from other "traditional" arrhythmia drug targets, such as ion channel proteins. This review will discuss some of the biology of CaMKII and focus on work that has been done on molecular, cellular, and whole animal models that together build a case for CaMKII as a pro-arrhythmic signal and as a potential therapeutic target for arrhythmias and structural heart disease.
KW - Arrhythmias
KW - Calmodulin kinase II
UR - http://www.scopus.com/inward/record.url?scp=33846888199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846888199&partnerID=8YFLogxK
U2 - 10.1016/j.cardiores.2006.12.009
DO - 10.1016/j.cardiores.2006.12.009
M3 - Review article
C2 - 17254559
AN - SCOPUS:33846888199
SN - 0008-6363
VL - 73
SP - 657
EP - 666
JO - Cardiovascular research
JF - Cardiovascular research
IS - 4
ER -